The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CemiplimAb-rwlc survivorship and epidemiology (CASE): A prospective study of safety and efficacy of cemiplimab in patients with advanced basal cell carcinoma in a real-world setting.
 
Soo J Park
Consulting or Advisory Role - Regeneron
Research Funding - Regeneron
 
David Ellison
No Relationships to Disclose
 
Ryan Michael Weight
Consulting or Advisory Role - Association of Community Cancer Centers (ACCC); Castle Biosciences; Immunocore; Novartis; Pfizer; Sanofi/Regeneron
Speakers' Bureau - Castle Biosciences; Immunocore
Patents, Royalties, Other Intellectual Property - Intellectual Property (Patent) with Royalty rights "Photoacoustic Detection of Circulating Analytes"
Expert Testimony - Norcal Insurance
 
Jade Homsi
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Regeneron
Expert Testimony - Boehringer Ingelheim
 
Guilherme Rabinowits
Consulting or Advisory Role - BostonGene; Castle Biosciences; replimune; Sanofi/Regeneron
 
Emily S. Ruiz
Consulting or Advisory Role - Checkpoint Therapeutics; Leo Pharma; Regeneron
Research Funding - PellePharm; Regeneron
 
John Strasswimmer
No Relationships to Disclose
 
Josh David Simmons
No Relationships to Disclose
 
Timothy J. Panella
No Relationships to Disclose
 
Ruben GW Quek
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Gregory Ursino
Stock and Other Ownership Interests - Bristol-Myers Squibb; Gilead Sciences; Johnson & Johnson; Novartis; Regeneron; Takeda
 
Jean-Francois Pouliot
Employment - AstraZeneca; Regeneron
Stock and Other Ownership Interests - Merck; Regeneron
 
Nikhil I. Khushalani
Stock and Other Ownership Interests - Amarin Corporation; Asensus Surgical; Bellicum Pharmaceuticals
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Castle Biosciences; Genzyme; Immunocore; Incyte; Instil Bio; Iovance Biotherapeutics; Jounce Therapeutics; Merck; NCCN/Pfizer; Nektar; Novartis; Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); HUYA Bioscience International (Inst); Merck (Inst); Modulation Therapeutics (Inst); Novartis (Inst); Regeneron (Inst); Replimune (Inst)
Other Relationship - Bristol-Myers Squibb/Celgene; Nektar; Regeneron; Replimune